ICOPE Program Feasibility in the Management of Myeloma Patients

Recruiting now · Not applicable

Conditions studied: Frailty, Multiple Myeloma

In brief

This project proposes to adapt monthly the existing ICOPE (Integrated Care for Older People) MONITOR program for elderly myeloma patients. This adaptation aims to detect earlier functional decline and prevent loss of autonomy.

Key facts

Study ID

NCT06247189

Run by

University Hospital, Toulouse

People needed

30

Starts

2025-12-03

Expected to finish

2026-12-30

Last updated by the study team

2025-12-22

Who can join

Age: 70 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female aged over 70 years,
• Patient with multiple myeloma
• WHO performance status 0-3,
• Patient eligible for first- or second-line treatment
• Patient willing to participate in ICOPE MONITOR program
• Patient or caregiver able to use digital tools of ICOPE MONITOR: application or chatbot (computer or tablet or smartphone)
• Patient with a life expectancy of more than 3 months,
• Patient or caregiver able to understand, read and speak French
• Person affiliated or benefiting from a social security.
• Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research)

You may not qualify if…

• Patient in palliative care
• Patient participating in a study evaluating another frailty prevention program
• Patient unable to understand the study
• Patient under court protection, guardianship or curatorship,
• Patient refusal.

Where it is running

• CHU de Toulouse — Toulouse, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.